News | November 12, 2021
Covaxin well tolerated with no safety concerns: Lancet
Covaxin is the only Covid-19 vaccine to have demonstrated efficacy data from phase III clinical trials against the Delta variant at 65.2%
Covaxin is the only Covid-19 vaccine to have demonstrated efficacy data from phase III clinical trials against the Delta variant at 65.2%
Bioanalytical approach to accelerate development efforts in the identification of compounds that can treat chlorine or sulfur mustard injuries
The drug helps in managing cholesterol
The solution helps the pharma enterprises drive efficiencies, save costs, and increase productivity
The preregistrations are aimed at registering both healthy children and those with comorbidities whereas preference will be given for children with comorbidities
Dr. Reddy's Laboratories has reported consolidated financial results for the period ended September 30, 2021
Through the mission an entire ecosystem for services from treatment to critical research will be created in every corner of the country
The implant is surgically inserted into the eye during a one-time, outpatient procedure and refilled every six months
The quarter also saw continued investment in new technologies and the successful implementation of several digitization and automation projects across operations
India reports 18 lakh stroke cases a year with 25 per cent patients below the age of 50
Subscribe To Our Newsletter & Stay Updated
